IPP Bureau

Novo Nordisk strikes $1bn deal for Lexicon’s oral obesity drug
Novo Nordisk strikes $1bn deal for Lexicon’s oral obesity drug

By IPP Bureau - March 29, 2025

Lexicon Pharmaceuticals announces exclusive license agreement with Novo Nordisk for LX9851

Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD
Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD

By IPP Bureau - March 29, 2025

Dupixent (dupilumab) approved as the first-ever biologic medicine in Japan for patients with Chronic Obstructive Pulmonary Disease (COPD)

WeylChem strengthens custom manufacturing with unified leadership
WeylChem strengthens custom manufacturing with unified leadership

By IPP Bureau - March 27, 2025

Dr. Benjamin Bechem, already leading WeylChem Organica and European custom manufacturing sales

European Commission approves Merck’s Capvaxive for prevention of invasive pneumococcal disease
European Commission approves Merck’s Capvaxive for prevention of invasive pneumococcal disease

By IPP Bureau - March 27, 2025

EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults

Bio-Thera & Dr Reddy’s execute commercialization pact for biosimilars Stelara & Simponi for SE Asia
Bio-Thera & Dr Reddy’s execute commercialization pact for biosimilars Stelara & Simponi for SE Asia

By IPP Bureau - March 27, 2025

Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2206 and BAT2506

GSK, UK Dementia Research Institute and Health Data Research UK to collaborate on first-of-its-kind dementia research initiative
GSK, UK Dementia Research Institute and Health Data Research UK to collaborate on first-of-its-kind dementia research initiative

By IPP Bureau - March 27, 2025

The first-of-its-kind study will evaluate potential association between GSK’s shingles vaccine and reduced dementia risk, building on growing body of evidence from observational and retrospective studies

Innovaoleo launches Omega 3 Star for food, nutraceutical and pet nutrition
Innovaoleo launches Omega 3 Star for food, nutraceutical and pet nutrition

By IPP Bureau - March 27, 2025

Omega 3 oil 18 EPA/12 DHA is highly demanded worldwide for its multiple benefits for human and animal health

Merck and Zebra Technologies collaborate to create safety and traceability solutions
Merck and Zebra Technologies collaborate to create safety and traceability solutions

By IPP Bureau - March 27, 2025

Collaboration combines data, identity capture and Web 3.0 crypto technologies to enhance product safety, traceability, and data integrity for AI systems

Mila Beaute raises $2.16 million in pre-series A round led by Rukam Capital
Mila Beaute raises $2.16 million in pre-series A round led by Rukam Capital

By IPP Bureau - March 27, 2025

The freshly infused capital will primarily be deployed towards expansion and research & development

Abbott launches intravascular lithotripsy trial aimed at clearing coronary arteries
Abbott launches intravascular lithotripsy trial aimed at clearing coronary arteries

By IPP Bureau - March 27, 2025

Abbott's investigational Coronary Intravascular Lithotripsy (IVL) System offers a new potential treatment by using sound pressure waves to treat arterial calcium blockages

Cadila launches Cadilose for constipation and hepatic encephalopathy
Cadila launches Cadilose for constipation and hepatic encephalopathy

By IPP Bureau - March 26, 2025

Glenmark launches nutrition program to fight malnutrition in Philippines
Glenmark launches nutrition program to fight malnutrition in Philippines

By IPP Bureau - March 26, 2025

This program, titled "Food Supplementation and Capacity Building Support for Improved Nutrition in Malinao, Aklan," aligns with the country’s national health

Alembic Pharma and Amlan International partner to advance poultry health in India
Alembic Pharma and Amlan International partner to advance poultry health in India

By IPP Bureau - March 26, 2025

Alembic Pharmaceuticals Ltd. and Amlan International sign exclusive strategic commercial agreement to make poultry health innovations accessible to Indian farmers and integrators

Merck inks $200 million deal for Hengrui's midstage heart disease drug
Merck inks $200 million deal for Hengrui's midstage heart disease drug

By IPP Bureau - March 26, 2025

Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region

Wipro announces AI Agent Solutions across healthcare industry
Wipro announces AI Agent Solutions across healthcare industry

By IPP Bureau - March 25, 2025

Wipro’s agents for Agentforce will elevate efficiency and customer satisfaction at healthcare companies

Latest Stories

Interviews

Packaging